The news comes on the heels of a recent decision from the FDA recommending a possible annual, bivalent COVID-19 vaccine for the public. Monovalent vaccines, the CDC’s report found, have shown “waning protection … against hospitalization.”
Researchers examined the immunity of bivalent vaccine recipients in different regions across the U.S. and were able to observe that bivalent recipients had “slightly higher protection against infection and significantly higher protection against death” than those who had received monovalent vaccinations.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.